|
Volumn 23, Issue 8, 2014, Pages 666-669
|
Chronic valproate or levetiracetam treatment does not influence cytokine levels in humans
|
Author keywords
Cytokines; Epilepsy; Immune system; Levetiracetam; Lymphocytes; Valproate
|
Indexed keywords
CYTOKINE;
ETIRACETAM;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
MONOCYTE CHEMOTACTIC PROTEIN 1;
TUMOR NECROSIS FACTOR ALPHA;
VALPROIC ACID;
ANTICONVULSIVE AGENT;
PIRACETAM;
ABSENCE OF SIDE EFFECTS;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD CELL COUNT;
CD3+ T LYMPHOCYTE;
CD4+ CD25+ T LYMPHOCYTE;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CLINICAL ARTICLE;
EPILEPSY;
FEMALE;
HUMAN;
IMMUNOLOGICAL PARAMETERS;
LEUKOCYTE COUNT;
MALE;
MIDDLE AGED;
NEUTROPHIL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
SEIZURE;
VERY ELDERLY;
YOUNG ADULT;
ANALOGS AND DERIVATIVES;
BLOOD;
BLOOD ANALYSIS;
DRUG EFFECTS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FLOW CYTOMETRY;
IMMUNOLOGY;
LYMPHOCYTE;
METABOLISM;
PROSPECTIVE STUDY;
ANTICONVULSANTS;
BLOOD CHEMICAL ANALYSIS;
CYTOKINES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EPILEPSY;
FEMALE;
FLOW CYTOMETRY;
HUMANS;
LEUKOCYTE COUNT;
LYMPHOCYTES;
MALE;
MIDDLE AGED;
NEUTROPHILS;
PIRACETAM;
PROSPECTIVE STUDIES;
VALPROIC ACID;
|
EID: 84906305861
PISSN: 10591311
EISSN: 15322688
Source Type: Journal
DOI: 10.1016/j.seizure.2014.04.011 Document Type: Article |
Times cited : (20)
|
References (13)
|